Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Insider Transactions

Date Name Title Type Shares Traded Price Range
Jan 01, 2006
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 200,000 --
Dec 06, 2005
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 --
Dec 06, 2005
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Dec 06, 2005
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Dec 06, 2005
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 --
Dec 06, 2005
Vice President Finance
Vice President Finance Grant, award or other acquisition pursuant to Rule 16b-3(d) 40,000 --
Dec 06, 2005
Vice President Finance
Vice President Finance Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Dec 06, 2005
Chief Scientific Officer
Chief Scientific Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 100,000 --
Dec 06, 2005
Chief Scientific Officer
Chief Scientific Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 30,000 --
Dec 06, 2005
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 --
Dec 06, 2005
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Dec 06, 2005
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 --
Dec 06, 2005
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Dec 06, 2005
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Dec 06, 2005
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 --
Sep 20, 2005
Director
Director Initial Statement of Beneficial Ownership of Securities -- --
Sep 20, 2005
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,000 --
Jul 05, 2005
Director, Chairman, CEO & President
Director, Chairman, CEO & President Open market or private purchase of non-derivative or derivative security 1,500 $4.33
Jun 29, 2005
Chief Scientific Officer
Chief Scientific Officer Open market or private purchase of non-derivative or derivative security 1,000 $4.20
Jun 29, 2005
Director, Chairman, CEO & President
Director, Chairman, CEO & President Open market or private purchase of non-derivative or derivative security 5,000 $4.19
May 19, 2005
Chief Scientific Officer
Chief Scientific Officer Open market or private purchase of non-derivative or derivative security 200 $4.70
May 19, 2005
Chief Scientific Officer
Chief Scientific Officer Open market or private purchase of non-derivative or derivative security 1,400 $4.72
May 18, 2005
Director, Chairman, CEO & President
Director, Chairman, CEO & President Open market or private purchase of non-derivative or derivative security 1,700 $4.83
May 18, 2005
Director, Chairman, CEO & President
Director, Chairman, CEO & President Open market or private purchase of non-derivative or derivative security 300 $4.80
May 18, 2005
Director, Chairman, CEO & President
Director, Chairman, CEO & President Open market or private purchase of non-derivative or derivative security 1,000 $4.69

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Copyright West LLC. Minimum 15 minutes delayed.